Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research Article
  • Published:

Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2)

Abstract

Recently, we cloned the human myo-inositol monophosphatase 2 (IMPA2) cDNA and established its map location to chromosome 18p11.2, a region previously implicated in bipolar disorder. Because the myo-inositol monophosphatase enzyme has been shown to be inhibited by lithium, an effective therapeutic agent for bipolar disorder, IMPA2 is a plausible positional and functional candidate gene. To permit comprehensive screening for variants we characterized the genomic structure and isolated the potential promoter of IMPA2. The gene was found to encode eight exons spanning ˜27 kb. The proximal 1-kb 5′ flanking region did not contain an obvious TATA box but multiple potential binding sites for Sp1 and consensus motifs for AP2 and other transcription factors were evident. Sequencing of the coding region and splice junctions in unrelated bipolar disorder patients detected novel variants. A missense mutation in exon 2, His76Tyr, was found in one patient. His76 is evolutionarily conserved and replacement with Tyr introduces a potential site for phosphorylation. The other polymorphisms included an Rsai polymorphism, ivs1-15g>A, and a T → C silent mutation in the third nucleotide of codon 53 in exon 2. By Fisher's exact test the silent mutation showed a trend for association (P = 0.051) with bipolar disorder suggesting that further scrutiny of this gene is warranted.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh SD, Nurnberger Jr JI et al. Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene Proc Natl Acad Sci USA 1994; 91: 5918–5921

    Article  CAS  Google Scholar 

  2. Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G et al. A high density genome scan detects evidence for a bipolar-disorder susceptibility locus on chromosome 13q32, and other potential loci on 1q32 and 18p11.2 Proc Natl Acad Sci USA 1999; 96: 5604–5609

    Article  CAS  Google Scholar 

  3. Stine OC, Xu J, Koskela R, McMahon FJ, Gschwend M, Friddle C et al. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect Am J Hum Genet 1995; 57: 1384–1394

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Nothen MM, Cichon S, Rohleder H, Hemmer S, Franzek E, Fritze J et al. Evaluation of linkage of bipolar affective disorder to chromosome 18 marker in a sample of 57 German families Mol Psychiatry 1999; 4: 76–84

    Article  CAS  Google Scholar 

  5. Yoshikawa T, Turner G, Esterling LE, Sanders AR, Detera-Wadleigh SD . A novel human myo-inositol monophosphatase gene, IMP. 18p, maps to a susceptibility region for bipolar disorder Mol Psychiatry 1997; 2: 393–397

    Article  CAS  Google Scholar 

  6. Sjoholt G, Molven A, Lovlie R, Wilcox A, Sikela JM, Steen VM . Genomic structure and chromosomal localization of human myo-inositol monophosphatase gene (IMPA) Genomics 1997; 45: 113–122

    Article  CAS  Google Scholar 

  7. Parthasarathy L, Vandal RE, Parthasarathy R, Devi CSS . Biochemical and molecular properties of lithium-sensitive myo-inositol monophosphatase Life Sci 1994; 54: 1127–1142

    Article  CAS  Google Scholar 

  8. Atack JR . Inositol monophosphatase, the putative therapeutic target for lithium Brain Res Rev 1996; 22: 183–190

    Article  CAS  Google Scholar 

  9. NIMH Collaborative Group for Bipolar Disorder: Nurnberger JI Jr, DePaulo JR, Gershon ES, Reich T, Blehar M, Edenberg H, et al. A genomic survey of bipolar illness in the NIMH Genetics Initiative Pedigrees: a preliminary report Am J Med Genet 1997; 74: 227–237

    Article  Google Scholar 

  10. Neuwald AF, York JD, Majerus PW . Diverse proteins homologous to inositol monophosphatase FEBS Lett 1991; 294: 16–18

    Article  CAS  Google Scholar 

  11. Azizkhan JC, Jensen DE, Pierce AJ, Wade M . Transcription from TATA-less promoters: dihydrofolate reductase as a model Crit Rev Eukaryotic Gene Expression 1993; 3: 229–254

    CAS  Google Scholar 

  12. Dynan WS, Tjian R . Control of eukaryotic messenger RNA synthesis by sequence specific DNA binding proteins Nature 1985; 316: 774–778

    Article  CAS  Google Scholar 

  13. Kadonaga JT, Jones KA, Tjian R . Promoter specific activation of RNA polymerase II transcription by Sp1 Trends Biochem Sci 1986; 11: 20–23

    Article  CAS  Google Scholar 

  14. Blake MC, Jambou RC, Swick AG, Kahn JW, Clifford J, Azizkhan JC . Transcriptional initiation is controlled by upstream GC-box interaction in a TATA-less promoter Mol Cell Biol 1990; 10: 6632–6641

    Article  CAS  Google Scholar 

  15. Olson EN . MyoD family: a paradigm for development? Genes Dev 1990; 4: 1454–1461

    Article  CAS  Google Scholar 

  16. Imagawa M, Chiu R, Karin M . Transcription factor AP-2 mediates induction by two different signal-transcription pathways: protein kinase C and cAMP Cell 1987; 51: 251–260

    Article  CAS  Google Scholar 

  17. Schwab SG, Hallmayer J, Lerer B, Albus M, Borrmann M, Honig S et al. Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis Am J Hum Genet 1998; 63: 1139–1152

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Elliot S Gershon for diagnosis of the families, Lori Oosterbahn for her assistance in isolating the cosmid clones, and Gordon Turner and Tracy Moses for their help in sequencing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S D Detera-Wadleigh.

Additional information

The sequences determined in this study are deposited in the GenBank under the accession numbers of AF025878 through AF025886

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshikawa, T., Padigaru, M., Karkera, J. et al. Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2). Mol Psychiatry 5, 165–171 (2000). https://doi.org/10.1038/sj.mp.4000688

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4000688

Keywords

Search

Quick links